The ReoPro Retavase Reperfusion of Stroke Safety Study (ROSIE) is an NIH-sponsored Phase II trial evaluating intravenous reteplase in combination with abciximab for the treatment of patients with ...

Background: Fluid-attenuated inversion recovery (FLAIR) vascular hyperintensity (FVH) might be useful for predicting and functional outcome in ischemic stroke patients after endovascular thrombectomy ...

Ischemic stroke (IS) and cardiovascular disease (CVD ... For this reason pharmacogenetics and pharmacogenomics opened a new era in the treatment of IS. Unfortunately, genetics studies to date ...

Hemorrhagic stroke studies, such as the INTERACT-4 trial, have also demonstrated the benefits of early blood pressure ...

Each year, an estimated 15 million people around the globe experience stroke, according to the World Health Organization, ...

The study demonstrated that mechanical thrombectomy is a safe and effective method for stroke patients in India, achieving ...

Learn about the types, symptoms, treatment, and importance of time in recognizing and treating strokes to save lives.

The following is a summary of “Bibliometric analysis of the usage of tenecteplase for stroke,” published in the November 2024 ...

A stroke can happen suddenly and cause major changes in a person’s life right away. The disruption of blood flow to the brain ...

VMPL New Delhi [India] November 7 Medtronic a global leader in healthcare technology unveiled results from the Prospective ...

India's first dedicated stroke registry, PRAAN, showcases mechanical thrombectomy's efficacy for acute ischemic stroke. Medtronic's study, involving 200 patients across 14 centers, shows high success ...